Angelika Wiatr

Angelika Wiatr

Auto-generated profile, based on publicly available information

Angelika Wiatr

Central Teaching Hospital of the Medical University of Lodz, ul. Pomorska 251, 92-213 Łódź, Poland

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 July 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
ASAleksandra Suszczyńska
Aleksandra Suszczyńska
EWEwa Wojtanowska
Ewa Wojtanowska
MMMarcin Mazur
Marcin Mazur
JKJulia Kozicka
Julia Kozicka
AWAngelika Wiatr
Angelika Wiatr
NTNatalia Tomoń
Natalia Tomoń
Gingival enlargement and epulis are common reactive lesions of the oral cavity with a multifactorial aetiology. While dental plaque is considered the primary initiating factor, systemic hormonal influences play a significant modulatory role in their development and clinical expression. This narrative review aims to summarise current evidence regarding the effects of sex steroid hormones on gingival enlargement and epulis, with particular emphasis on pregnancy-associated lesions and hormonal fluctuations throughout life. A literature search was conducted using PubMed and Google Scholar, focusing on studies investigating the effects of oestrogen and progesterone on periodontal tissues. The available evidence indicates that sex hormones influence inflammatory responses, vascular function, immune activity, microbial composition, and connective tissue metabolism within the periodontium. The findings suggest that hormonal changes do not directly initiate gingival disease but act as modifying factors that increase tissue susceptibility to local irritants, particularly dental plaque. Understanding these mechanisms is essential for improving prevention and clinical management of hormonally influenced gingival conditions.

18 June 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
EWEwa Wojtanowska
Ewa Wojtanowska
EJEwa Jachimczak
Ewa Jachimczak
PJPaulina Jaruga
Paulina Jaruga
KGKarolina Grodkowska-Szukała
Karolina Grodkowska-Szukała
JKJulia Kozicka
Julia Kozicka
AWAngelika Wiatr
Angelika Wiatr
Obesity (BMI ≥30 kg/m²) is a growing global health problem that significantly affects respiratory function and disease. Excess adipose tissue can alter lung mechanics, reducing respiratory system compliance and lowering functional residual capacity while increasing airway resistance, particularly when lying down. Concurrently, obesity promotes a chronic, low-grade inflammatory state through hypertrophic adipocytes and macrophage infiltration, resulting in the overproduction of cytokines (e.g. IL-6 and TNF-α), adipokines (e.g. leptin) and mediators (e.g. HMGB1). These mechanical and inflammatory changes contribute to airway remodelling, endothelial dysfunction and an increased susceptibility to chronic and infectious respiratory diseases. This review summarises the current evidence on the impact of obesity on asthma, obstructive sleep apnoea (OSA), and SARS-CoV-2 infection. In asthma, obesity defines a distinct phenotype that is often difficult to treat, characterised by more persistent disease, a reduced response to inhaled glucocorticoids and spirometric changes that improve with weight loss. In OSA, obesity — particularly central and visceral fat — narrows the upper airway, destabilises ventilatory control, and markedly increases disease prevalence and severity. Indices of abdominal adiposity correlate more strongly with apnoea–hypopnoea burden than BMI alone. In the context of SARS-CoV-2 infection, obesity is a major risk factor for severe disease, higher rates of hospitalisation, ICU admission, ARDS and death, with risk rising across obesity classes. Obese patients also more often require invasive ventilation or ECMO, and they may experience prolonged respiratory impairment and long-term symptoms of post-viral fatigue.

2 July 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
MKMikolaj Kurczynski
Mikolaj Kurczynski
ASAleksandra Suszczyńska
Aleksandra Suszczyńska
AWAngelika Wiatr
Angelika Wiatr
KJKsenia Jakubiak
Ksenia Jakubiak
JWJulia Witkowska
Julia Witkowska
MKMonika Krasoń
Monika Krasoń
The foundation of current prostate cancer diagnostics still remains the interpretation of total PSA (tPSA) results, but it is an imperfect test due to its low specificity and diagnostic ambiguities in patients within the "gray zone," meaning patients with a result of (2.0/4.0–10.0 ng/mL). This fact leads to many cases of "overdiagnosis" and an excess of unnecessarily performed biopsies. This article summarizes the diagnostic value of blood-based biomarkers and tests (PHI, 4Kscore, Stockholm3) as well as urine-based ones (SelectMDx and ExoDx). These tests achieve high AUC values (0.76–0.88) and a high negative predictive value (up to 98%) in detecting clinically significant prostate cancer (csPCa, GG ≥ 2), underscoring their advantage over traditional methods. Combining them with multiparametric MRI allows for a 30–65% reduction in unnecessary biopsies while maintaining high oncological safety for the patient. Despite promising results, the high costs of individual tests, lack of reimbursement, and absence of full standardization in international urological guidelines remain a continuous challenge and a hurdle to their introduction into daily practice.